Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

A physiologically based pharmacokinetic model for the broad-spectrum antimicrobial zinc pyrithione: I. Development and verification.

Diamond GL, Skoulis NP, Jeffcoat AR, Nash JF.

J Toxicol Environ Health A. 2017;80(2):69-90. doi: 10.1080/15287394.2016.1245123. Epub 2017 Jan 13.

PMID:
28085645
2.

Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration.

Garner CE, Sumner SC, Davis JG, Burgess JP, Yueh Y, Demeter J, Zhan Q, Valentine J, Jeffcoat AR, Burka LT, Mathews JM.

Toxicol Appl Pharmacol. 2006 Aug 15;215(1):23-36. Epub 2006 Mar 2.

PMID:
16513153
3.

Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.

Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BE, Valentine JL, Stinchcombe T, Boan J, Crowell JA, Zeisel SH.

Nutr Cancer. 2004;48(2):160-70.

PMID:
15231450
4.

Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.

Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH.

Am J Clin Nutr. 2002 Nov;76(5):1126-37.

PMID:
12399289
5.

Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.

Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM, Crowell JA, Zeisel SH.

Am J Clin Nutr. 2002 Jan;75(1):126-36.

PMID:
11756070
6.

Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection.

Thomas BF, Zeisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, Brown SS, Bloeden LT, Dix KJ, Jeffcoat AR.

J Chromatogr B Biomed Sci Appl. 2001 Sep 5;760(2):191-205.

PMID:
11530977
7.

Disposition of propargyl alcohol in rat and mouse after intravenous, oral, dermal and inhalation exposure.

Dix KJ, Coleman DP, Fossett JE, Gaudette NF Jr, Stanley AP, Thomas BF, Jeffcoat AR.

Xenobiotica. 2001 Jun;31(6):357-75.

PMID:
11513248
8.

Effect of habitual dietary-protein intake on appetite and satiety.

Long SJ, Jeffcoat AR, Millward DJ.

Appetite. 2000 Aug;35(1):79-88.

PMID:
10896764
9.

Identification of urinary metabolites of isoprene in rats and comparison with mouse urinary metabolites.

Buckley LA, Coleman DP, Burgess JP, Thomas BF, Burka LT, Jeffcoat AR.

Drug Metab Dispos. 1999 Jul;27(7):848-54.

PMID:
10383931
10.

Isolation and identification of novel metabolites of gemfibrozil in rat urine.

Thomas BF, Burgess JP, Coleman DP, Scheffler NM, Jeffcoat AR, Dix KJ.

Drug Metab Dispos. 1999 Jan;27(1):147-57.

PMID:
9884324
11.
12.

Determination of ibogaine in plasma by gas chromatography--chemical ionization mass spectrometry.

Ley FR, Jeffcoat AR, Thomas BF.

J Chromatogr A. 1996 Feb 2;723(1):101-9.

PMID:
8819825
13.

Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine.

Perez-Reyes M, Jeffcoat AR, Myers M, Sihler K, Cook CE.

Psychopharmacology (Berl). 1994 Dec;116(4):428-32.

PMID:
7701044
14.

Disposition and pharmacokinetics of isopropanol in F-344 rats and B6C3F1 mice.

Slauter RW, Coleman DP, Gaudette NF, McKee RH, Masten LW, Gardiner TH, Strother DE, Tyler TR, Jeffcoat AR.

Fundam Appl Toxicol. 1994 Oct;23(3):407-20.

PMID:
7835542
15.

Determination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometry.

Thomas BF, Jeffcoat AR, Myers MW, Mathews JM, Cook CE.

J Chromatogr B Biomed Appl. 1994 May 13;655(2):201-11.

PMID:
8081466
16.

Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.

Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M.

Drug Metab Dispos. 1993 Jul-Aug;21(4):717-23.

PMID:
8104133
17.

Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans.

Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, Perez-Reyes M.

Drug Metab Dispos. 1992 Nov-Dec;20(6):856-62.

PMID:
1362938
18.

Pharmacokinetics of [3H]-ivermectin in the dog following oral administration of a beef-based chewable formulation containing ivermectin alone or in combination with pyrantel pamoate.

Clark JN, Daurio CP, Skelly BJ, Cheung EN, Jeffcoat AR.

J Vet Pharmacol Ther. 1992 Jun;15(2):217-20. No abstract available.

PMID:
1433483
20.

Bioavailability of ivermectin administered orally to dogs.

Daurio CP, Cheung EN, Jeffcoat AR, Skelly BJ.

Vet Res Commun. 1992;16(2):125-30.

PMID:
1496814
21.

The pharmacologic effects of daily marijuana smoking in humans.

Perez-Reyes M, White WR, McDonald SA, Hicks RE, Jeffcoat AR, Cook CE.

Pharmacol Biochem Behav. 1991 Nov;40(3):691-4.

PMID:
1666929
22.

Clinical effects of daily methamphetamine administration.

Perez-Reyes M, White WR, McDonald SA, Hicks RE, Jeffcoat AR, Hill JM, Cook CE.

Clin Neuropharmacol. 1991 Aug;14(4):352-8.

PMID:
1913701
23.

Clinical effects of methamphetamine vapor inhalation.

Perez-Reyes M, White WR, McDonald SA, Hill JM, Jeffcoat AR, Cook CE.

Life Sci. 1991;49(13):953-9.

PMID:
1886456
24.

Plasma levels of methamphetamine after smoking of methamphetamine hydrochloride.

Cook CE, Jeffcoat AR, Perez-Reyes M, Sadler BM, Hill JM, White WR, McDonald S.

NIDA Res Monogr. 1990;105:578-9. No abstract available.

PMID:
1876127
25.

Metabolism and distribution of bromodichloromethane in rats after single and multiple oral doses.

Mathews JM, Troxler PS, Jeffcoat AR.

J Toxicol Environ Health. 1990 May;30(1):15-22.

PMID:
2112202
26.
27.

Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking.

Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE.

Drug Metab Dispos. 1989 Mar-Apr;17(2):153-9.

PMID:
2565204
28.

Interaction between marihuana and ethanol: effects on psychomotor performance.

Perez-Reyes M, Hicks RE, Bumberry J, Jeffcoat AR, Cook CE.

Alcohol Clin Exp Res. 1988 Apr;12(2):268-76.

PMID:
2837105
29.

Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats.

Mast RW, Jeffcoat AR, Sadler BM, Kraska RC, Friedman MA.

Food Chem Toxicol. 1983 Dec;21(6):807-10.

PMID:
6686586
30.

Phencyclidine disposition in humans after small doses of radiolabeled drug.

Cook CE, Perez-Reyes M, Jeffcoat AR, Brine DR.

Fed Proc. 1983 Jun;42(9):2566-9.

PMID:
6852275
31.

Determination of tissue UDP-glucuronic acid levels by high-pressure liquid chromatography.

Schiller CM, Dieringer CS, Twine ME, Jeffcoat AR.

Anal Biochem. 1982 Nov 15;127(1):68-72. No abstract available.

PMID:
7165094
32.

Free-base cocaine smoking.

Perez-Reyes M, Di Guiseppi S, Ondrusek G, Jeffcoat AR, Cook CE.

Clin Pharmacol Ther. 1982 Oct;32(4):459-65.

PMID:
7116761
33.

Phencyclidine disposition after intravenous and oral doses.

Cook CE, Brine DR, Jeffcoat AR, Hill JM, Wall ME, Perez-Reyes M, Di Guiseppi SR.

Clin Pharmacol Ther. 1982 May;31(5):625-34.

PMID:
7075111
34.

Zinc pyridinethione: serum metabolites of zinc pyridinethione in rabbits, rats, monkeys, and dogs after oral dosing.

Gibson WB, Jeffcoat AR, Turan TS, Wendt RH, Hughes PF, Twine ME.

Toxicol Appl Pharmacol. 1982 Feb;62(2):237-50. No abstract available.

PMID:
7058528
35.

Zinc pyridinethione: urinary metabolites of zinc pyridinethione in rabbits, rats, monkeys, and dogs after oral dosing.

Jeffcoat AR, Gibson WB, Rodriguez PA, Turan TS, Hughes PF, Twine ME.

Toxicol Appl Pharmacol. 1980 Oct;56(1):141-54. No abstract available.

PMID:
7444962
36.

Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.

Pitt CG, Gratzl MM, Jeffcoat AR, Zweidinger R, Schindler A.

J Pharm Sci. 1979 Dec;68(12):1534-8.

PMID:
529046
37.

Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers.

Pitt CG, Jeffcoat AR, Zweidinger RA, Schindler A.

J Biomed Mater Res. 1979 May;13(3):497-507.

PMID:
438232
38.

Biotransformation products of 3,4,4'-trichlorocarbanilide in rat, monkey, and man.

Birch CG, Hiles RA, Eichhold TH, Jeffcoat AR, Handy RW, Hill JM, Willis SL, Hess TR, Wall ME.

Drug Metab Dispos. 1978 Mar-Apr;6(2):169-76.

PMID:
26533
39.

The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.

Jeffcoat AR, Handy RW, Francis MT, Willis S, Wall ME, Birch CG, Hiles RA.

Drug Metab Dispos. 1977 Mar-Apr;5(2):157-66.

PMID:
15808

Supplemental Content

Loading ...
Support Center